Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect
Language: 
English
Short Title: 
Selective killing of cancer cells by leaf extract of Ashwagandha
Abstract: 

PURPOSE: Ashwagandha is regarded as a wonder shrub of India and is commonly used in Ayurvedic medicine and health tonics that claim its variety of health-promoting effects. Surprisingly, these claims are not well supported by adequate studies, and the molecular mechanisms of its action remain largely unexplored to date. We undertook a study to identify and characterize the antitumor activity of the leaf extract of ashwagandha. EXPERIMENTAL DESIGN: Selective tumor-inhibitory activity of the leaf extract (i-Extract) was identified by in vivo tumor formation assays in nude mice and by in vitro growth assays of normal and human transformed cells. To investigate the cellular targets of i-Extract, we adopted a gene silencing approach using a selected small hairpin RNA library and found that p53 is required for the killing activity of i-Extract. RESULTS: By molecular analysis of p53 function in normal and a variety of tumor cells, we found that it is selectively activated in tumor cells, causing either their growth arrest or apoptosis. By fractionation, purification, and structural analysis of the i-Extract constituents, we have identified its p53-activating tumor-inhibiting factor as with a none. CONCLUSION: We provide the first molecular evidence that the leaf extract of ashwagandha selectively kills tumor cells and, thus, is a natural source for safe anticancer medicine.

Author(s): 
Widodo, Nashi
Kaur, Kamaljit
Shrestha, Bhupal G.
Takagi, Yasuomi
Ishii, Tetsuro
Wadhwa, Renu
Kaul, Sunil C.
Item Type: 
Journal Article
Publication Title: 
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research
Journal Abbreviation: 
Clin. Cancer Res.
Publication Date: 
Apr 1, 2007
Publication Year: 
2007
Pages: 
2298-2306
Volume: 
13
Issue: 
7
ISSN: 
1078-0432
DOI: 
10.1158/1078-0432.CCR-06-0948
Library Catalog: 
NCBI Published Medical (?)
Extra: 
PMID: 17404115

Turabian/Chicago Citation

Nashi Widodo, Kamaljit Kaur, Bhupal G. Shrestha, Yasuomi Takagi, Tetsuro Ishii, Renu Wadhwa and Sunil C. Kaul. Apr 1, 2007. "Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect." Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 13: 7: 2298-2306. 10.1158/1078-0432.CCR-06-0948.

Wikipedia Citation

<ref> {{Cite journal | doi = 10.1158/1078-0432.CCR-06-0948 | issn = 1078-0432 | volume = 13 | pages = 2298-2306 | last = Widodo | first = Nashi | coauthors = Kaur, Kamaljit, Shrestha, Bhupal G., Takagi, Yasuomi, Ishii, Tetsuro, Wadhwa, Renu, Kaul, Sunil C. | title = Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect | journal = Clinical Cancer Research: An Official Journal of the American Association for Cancer Research | date = Apr 1, 2007 | pmid = | pmc = }} </ref>